Understanding the Silent Threat
The silent threat of a brain aneurysm – a balloon-like protrusion in a brain blood vessel – ruptures, and it can be a stroke, disability or even death. As the world’s population grows older and life patterns increase risk, there’s never been a more urgent need for brain aneurysm treatment.
Market Overview
The Brain Aneurysm Treatment Market size is projected to reach US$ 11.06 billion by 2031 from US$ 3.18 billion in 2022. The market is expected to register a CAGR of 15.0% in 2023–2031.
Key Market Drivers
The market is being driven by a few trends:
Growing Presence: An increasing number of brain aneurysms in the aged, is a leading factor.
Advancements in Technologies: Invasive therapies such as endovascular coiling and surgical clipping have changed the way we treat them.
Better Diagnostic Equipment: CT Scans and MRIs have made detection and diagnosis earlier.
Majority of Healthcare Spending: Growing Healthcare infrastructure investment and growing healthcare expenditure are driving the market.
Market Segmentation
The brain aneurysm treatment market can be divided based on these:
By Type
- Normal Saline
- Hypertonic Saline
- Hypotonic Saline
- Balanced Saline
By Packaging Type
- Flexible Bags
- Plastic Bottles
- Glass Bottles
By Application
- Intravenous
- Ophthalmology
- Wound Care
- Endoscopy
- Skin Abrasion
By Route of Administration
- Intravenous and Topical
Geography:
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East and Africa
Competitive Landscape
The market is fragmented by some of the leading market players such as:
- Fresenius Kabi AG
- Merck KGaA
- AdipoGen Life Sciences Inc
- Enzo Life Sciences Inc
- ICU Medical Inc
- Grifols SA
- Geno Technology Inc
- B Braun Medical Inc
- Pfizer Inc
These are companies that are looking to come up with new treatments, bolster their reach and make the right connections to gain market share.
Market Challenges and Opportunities
And though the market is growing, it still has its difficulties:
Costly Treatment: Advanced treatment and devices are expensive and not available to most patients.
Contingency of Risks: Both invasive and endovascular surgery are not free of risk.
But there’s a lot more in the market too:
New Markets: Small countries have untapped potential for expansion.
Telemedical and Remote Monitoring: Digital medical solutions can be used to make patient care more efficient and less expensive.
Individualized Medicine: Individualized treatment based on patient factors can increase success rates.
Frequently Asked Questions
What is a Brain Aneurysm?
Brain aneurysm: an abnormal bulge or swelling in a blood vessel in the brain. If it ruptures, the brain will bleed profusely, causing stroke, disability or death.
Why the Brain Aneurysm Therapy Market is Expanding?
Risk factors such as high blood pressure, smoking and familial history are also putting increasing pressure on the brain aneurysm treatment market, which is being pushed by improvements in diagnostic methods and treatments.
What Are The Main Treatments for the Brain Aneurysm Treatment Market?
Clipping: Surgery to detach the aneurysm.
Coiling: Minimally invasive procedure to fill in the aneurysm with tiny metal coils.
Endovascular repair: Minimally invasive repair of the aneurysm with catheters and stents.
What are the Treatment Obstacles for the Brain Aneurysm Treatment Market?
Precocious: The aneurysm can’t be seen until it ruptures.
Risks of surgery: There is always a chance of bleeding, stroke and infection during surgery.
Extremely expensive: Extreme treatments are quite expensive.
What are the Future Approaches to Treat Brain Aneurysm?
Low-invasive procedures: Increased attention to less invasive procedures to reduce risks and recovery.
Superior imaging: Newer imaging systems for early diagnosis and tailored treatment.
Anti-angryan therapies: Invention of antiangryan drugs that will halt aneurysm formation and rupture.
Personalized medicine: Individualized treatment plan for each patient.
